Profile
Keensight Capital is a European Growth Buyout investor headquartered in Europe, with a focus on Technology and Healthcare sectors. The firm partners with fast-growing and profitable companies, providing capital, strategic guidance, and operational support. Keensight Capital boasts a team rich in diversity, comprising members from 30 different nationalities, and leverages over 25 years of experience in its focus areas. Their emphasis on responsible investing and ESG principles sets them apart as a conscientious capital provider.
Keensight Capital invests in companies with revenues ranging from €10m to €400m, backing both minority and majority stakes with investment tickets between €10-800m. The firm primarily targets the Technology and Healthcare sectors, focusing on European-based companies with international operations. As of the end of 2025, Keensight Capital managed over €8bn in assets. They offer tailor-made financing solutions to drive organic growth, strategic acquisitions, and liquidity provisions.
Notable portfolio companies include Bedfont Scientific, a leader in non-invasive breath analysis medical devices; Decision Focus, a software developer for Governance, Risk, and Compliance solutions; Isto Biologics, a regenerative MedTech company; and Uve, which provides data management and analytics software for the Consumer-Packaged Goods industry.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.